Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

阿美利特 - NMPA Drug Approval Details

Approvals/NMPA/Terazosin Hydrochloride Capsules

Approved

化学药品

Terazosin Hydrochloride Capsules

哈药集团制药总厂,哈药集团三精儿童大药厂(有限公司)🇨🇳 National Medical Products Administration

Approval Date: Jun 29, 2020
Approval ID: 7Leaf56BC8D
Company: 哈药集团制药总厂,哈药集团三精儿童大药厂(有限公司)
Type: 化学药品

Approval Details

Approval Id: 7Leaf56BC8D
Approval Number: 国药准字H19980106
Generic Name: 盐酸特拉唑嗪胶囊
Generic Name En: Terazosin Hydrochloride Capsules
Brand Name: 阿美利特
Drug Type: 化学药品
Dosage Form: 胶囊剂
Strength: 2mg
Reg Date: 2020-06-29
Company Name: 哈药集团制药总厂,哈药集团三精儿童大药厂(有限公司)
Production Company Name: 哈药集团制药总厂,哈药集团三精儿童大药厂(有限公司)
Production Company Address: 哈尔滨市南岗区学府路109号，黑龙江省孙吴县高科技园区三精路6号

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 29, 2020

Approval ID

7Leaf56BC8D

Type

化学药品

Back to NMPA Approvals